what is the difference between semaglutide compound and tirzepatide compound Concerns Surrounding Compounded GLP-1s Mount As Shortages of Tirzepatide, End Compounded Semaglutide & Tirzepatide 2025:

Weight regain and cardiometabolic effects after withdrawal of semaglutide: the STEP 1 trial extension

Exenatide once a week assisted more patients in reaching the majority of ADA-recommended therapeutic goals than treatment with sitagliptin, pioglitazone, or insulin glargine

The number of patients at the 4-milligram dose who discontinued treatment due to side effects was lower than the placebo group, which Skovronsky called "remarkable to see." Around 4% of patients on that dose stopped the drug due to side effects, compared with nearly 5% with the placebo

dipyridamole (Moderate risk of reduced effectiveness during stress testing)

Accessing Affordable GLP-1 Therapy Without Insurance Insurance coverage for weight loss medications remains inconsistent across plans, with many policies classifying semaglutide as cosmetic rather than medical treatment